Background: The ankle-brachial index (ABI) is a simple, non-invasive, and inexpensive method used in the diagnosis of peripheral arterial disease (PAD) and can identify individuals at risk for cardiovascular disease in other arteries of the body, especially the coronary and carotid arteries. The primary objective of this study was to assess whether patients with an ABI < 0.9 have more severe coronary artery disease detected on coronary angiography compared to patients with a normal ABI.
Introduction
Atherosclerosis, a chronic disease that systemically affects the arteries, is an important cause of morbidity and mortality in humans [1, 2] .
The etiological, pathophysiological, and clinical aspects of atherosclerosis are multifactorial and include genetics, aging, hypertension, diabetes mellitus, dyslipidemia, smoking, a sedentary lifestyle, immune system, inflammation and other risk factors [3] [4] [5] [6] .
Atherosclerotic changes in the arterial wall progress slowly and quietly after starting in the early stages of life. However, the clinical manifestations of the disease usually appear at the advanced stage [6, 7] .
Since atherosclerosis is a systemic disease, any artery may be affected. However, the most common clinical events arise from atheroma in the coronary arteries, carotid arteries, lower limb (LL) arteries, and aorta [2, 8] .
The ankle-brachial index (ABI) is a simple, non-invasive, and inexpensive method used in the diagnosis of peripheral arterial disease (PAD) and can identify individuals at risk for cardiovascular disease in other arteries of the body, especially the coronary and carotid arteries. The normal range of this index is 0.9 -1.4 [9] .
An ABI < 0.9 has 90% sensitivity and 98% specificity in detecting ≥ 50% stenosis in LL arteries [10] , and is associated with an increased risk of myocardial infarction and stroke [9, 11] .
The primary objective of this study was to assess whether patients with an ABI < 0.9 have more severe coronary artery disease (CAD) detected on coronary angiography compared to patients with a normal ABI. The secondary objectives were to describe and compare the clinical characteristics of patients with normal and abnormal ABI and verify whether ABI is an independent predictor of CAD.
Material and Methods
This is a prospective, analytical, cross-sectional study that was performed from July 1, 2013 to June 31, 2014 (real world study with duration of recruitment defined by protocol) that recruited 163 patients according to the inclusion and exclusion criteria described below. This study was performed in accordance with the ethical principles of clinical research and was approved by the clinical research ethics committee of the institution where it was performed (in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments).
Inclusion criteria include patients with a clinical diagnosis of stable angina (Canadian Cardiovascular Society classification III/IV), age ≥ 50 years, diabetes mellitus and/or smoking associated two or more other classic risk factors for coronary disease, and moderate or severe ischemia on myocardial scintigraphy (therefore with an indication for coronary angiography).
Exclusion criteria include presence of severe lung or liver comorbidities (life expectancy < 3 years), established diagnosis or relevant clinical suspicion of cancer, prior coronary artery bypass surgery or percutaneous coronary intervention and personal antecedent of revascularization to treat PAD.
All patients admitted to the invasive cardiology and hemodynamic laboratory of our institution diagnosed with chronic CAD and clinical indication for coronary angiography were evaluated as potential participants. Patients in accordance to inclusion and exclusion criteria were invited to participate and those who agreed were provided written informed consent.
Thereafter, through application of questionnaires the variables of interest were collected, and then ABI measurements were performed. Coronary angiography reports were collected, which included the description of coronary stenoses. The interventional cardiologist was blinded to the study protocol.
For the ABI measurements, a cuff with a length and width compatible with the diameter of the studied segment was used to measure the arterial systolic pressure of the upper and LLs. The ABI was measured using a portable vascular Doppler scanning MEDPEJH (Sao Paulo, Brazil) 10 MHz DV 2001 model and a BICH aneroid sphygmomanometer (Sao Paulo, Brazil).
All measurements were performed with the patient in a supine position after a 10-min rest. The systolic pressures of the posterior tibial and dorsalis pedis arteries were measured. The highest of these pressures was divided by the highest systolic pressure found in the brachial artery of the upper limbs to obtain the ABI. The index was expressed as a function of the member with the lowest index.
The presence of stenosis ≥ 30% was the criteria used to define coronary atherosclerosis. In case there was more than one stenosis per analyzed vessel, the most severe was taken into account. To assess severity, we analyzed the largest percentage of stenosis of each artery affected by atherosclerotic disease. Stenoses were classified as 30-49% and 50-100% (named as ≥ 50%).
Patients were divided into those with an ABI < 0.9 (abnormal ABI group) and those with an ABI 0.9 -1.4 (normal ABI). Patients with an ABI > 1.4 were not included in the statistical analysis.
Categorical variables were expressed as percentages, while normally distributed numeric variables were expressed as average and standard deviation. The patients' clinical characteristics are shown according to their frequency distribution.
Pearson's Chi-square and Student's t-tests were used to compare variables between groups. As the rates of stenoses > 50% in the coronary arteries were different between the groups, a Poisson regression model was used to evaluate whether ABI was an independent predictor of stenoses > 50%.
Values of P ≤ 0.05 were statistically significant. Statistical Package for the Social Sciences (SPSS) v 21 was used to store and analyze the variables.
Results
From July 1, 2013 to June 31, 2014, 656 patients underwent coronary angiography in our institution but a total of 163 patients (25%) were included in this study according to inclusion and exclusion criteria.
There were 101 men (62%) and 62 women (38%). The mean age was 62.5 ± 9.71 years. The prevalence of ABI < 0.9 was 9.8%.
The average age of patients with abnormal ABI was higher than those with this index normal (68.9 ± 9.4 versus 61.8 ± 9.5 years, P = 0.005). Table 1 shows ABI according to different age groups.
The patients' clinical characteristics were: hypertension 134 patients (82.2%), smoking 89 (54.6%), diabetes mellitus 74 (45.4%), family history of CAD 72 (44.1%), dyslipidemia 69 (42.3%), obesity 39 (23.9%), arrhythmia 16 (9.8%), peripheral vascular insufficiency 11 (6.7%), stroke 10 (6.1%), chronic kidney disease six (3.7%), liver disease six (3.7%) Ankle-Brachial Index and Coronary Lesions Cardiol Res. 2015;6(1):216-220
and chronic obstructive pulmonary disease five (3.1%). There were no differences of the clinical profiles between patients with normal and abnormal ABI ( Table 2) . Results of coronary angiographies have shown that in the left coronary artery, stenoses ≥ 30% occurred in 7.9% patients (30-49% in 5.5% and ≥ 50% in 2.4%). In the left anterior descending artery (LAD), stenoses were ≥ 30% in 57.6% of patients (30-49% in 18.4% and ≥ 50% in 39.2%). In the circumflex artery (LCX), there were stenoses ≥ 30% in 38% of patients (30-49% in 14.7% and ≥ 50% in 23.3%). In the right coronary artery (RCA), stenoses ≥ 30% occurred in 47.2% of patients (30-49% in 12.8% and ≥ 50% in 34.4%).
A comparative analysis of coronary stenoses (30-49% and > 50%) between the groups is shown in Table 3 .
On multivariate Poisson regression, an ABI < 0.9 was only an independent predictor of stenosis ≥ 50% in the LAD (odds ratio (OR): 2.05 (1.39 -3.04), P < 0.001).
Discussion
Patients with an ABI < 0.9 had a higher prevalence of stenoses ≥ 50% in the LAD and left main than those with a normal ABI. An abnormal ABI was an independent predictor of lesions ≥ 50% in LAD.
We observe that the prevalences of stenoses ≥ 50% in the RCA and in the LCX were numerically higher in patients with abnormal ABI, but without statistical differences (there was a trend in the RCA). We believe that a study with more patients than our study may find significant differences in these arteries.
In this study, the prevalence of abnormal ABI was higher in older patients, a finding that is consistent with that of previous studies, emphasizing that aging is associated with a higher probability of abnormal ABI [12] .
The association between smoking and the risk of PAD as well as dyslipidemia and CAD has been established in the literature, but in our study there was no difference in clinical profile between the groups [13] .
In patients at high risk for CAD, the prevalence of an ABI < 0.9 is higher than that in the general population, reaching 42% [13] [14] [15] . Despite the fact that our study population is at high risk for CAD, we did not confirm the previously published findings.
The ABI indicates atherosclerotic involvement of the LL arteries, and values < 0.9 are associated with a significantly increased cardiovascular risk, particularly myocardial infarction and stroke, independent of other risk factors [16, 17] .
A study that evaluated almost 4,393 patients demonstrated that patients with an ABI < 0.9 had a 3.7-fold higher risk of cardiovascular death compared with those with normal values [18] .
Data from the Framingham Offspring Study (3,113 patients) revealed that the prevalence of CAD in patients with an ABI < 0.9 was three times higher than that in patients with a normal index (30% versus 10%, P < 0.0001) [19] .
Studies have shown that patients with an ABI < 0.9 had a higher prevalence of multi-vessel CAD than those with a normal index [20, 21] .
Zuo et al and Papamichael et al evaluated associations between ABI and CAD extent and severity using the Gensini score and revealed an association between abnormal ABI and higher score [22, 23] .
Nonetheless, the Gensini score does not evaluate severity of CAD according to specific coronary artery [22, 23] . In our study, we analyzed stenoses according to its distribution in specific coronary arteries because the patient's prognosis also depends on which artery is compromised. For example, lesions in the LAD determine high risk for patients.
Banerjee et al demonstrated that in patients with chronic stable CAD, an abnormal ABI confers an increased risk of cardiovascular events, independent from traditional risk factors [24] . These results confirmed previous study published by Lee et al [25] .
In stable coronary heart disease, cardiovascular events result from demand ischemia or occlusion of the coronary artery due to atheroma growth, which could lead to total vessel obstruction [26] .
Our findings of increased rates of stenosis ≥ 50% in the LAD in patients with an ABI < 0.9 may help explain the occurrence of coronary events in patients with an abnormal ABI reported in the literature, and generated the hypothesis that this higher prevalence of these stenoses may be the underlying pathophysiology of the clinical manifestations. Oliveira et al Cardiol Res. 2015;6(1):216-220
In conclusion, patients with an ABI < 0.9 had more lesions ≥ 50% in the LAD coronary artery than those with a normal ABI. Besides, this abnormal index was an independent predictor of these lesions. Hence, as hypothesis, this higher frequency of stenosis ≥ 50% may contribute to occurrence of coronary events in this group of patients.
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